ClinicalTrials.Veeva

Menu

Percutaneous Imaging-guided Cryoblation of the Anterior Abdominal Wall Endometriosis Scars (ENDOMET)

U

University Hospital, Strasbourg, France

Status

Enrolling

Conditions

Endometriosis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Endometriosis is a common condition affecting 10% of women. It is characterized by the presence of ectopic endometrial cells. This pathology most frequently develops in the ovaries, utero-sacral ligaments and pelvic peritoneum, but also in the recto-sigmoid. Rarely, these lesions are found outside the pelvis, and even more exceptionally in the abdominal wall (in 0.03 to 1% of cases).

Cryotherapy has already been used for many years to treat soft tissue tumors (kidney and prostate tumors). It has also been successfully used by interventional radiologists to treat parietal desmoid tumors. After discussions with radiologists, given the similarity of location and extension of wall endometriosis lesions with desmoid tumours, the successes observed, and the scarcity of studies in the literature, it seemed appropriate to the investigators to study this new therapy.

The aim of this study was to investigate the efficacy of cryotherapy on parietal endometriosis lesions.

Enrollment

29 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult woman (≥18 years old) Having benefited from cryotherapy of an abdominal wall endometriosis nodule between January 6, 2020 and January 2, 2023.
  • Subject not objecting to the reuse of their data for the purposes of this research

Exclusion criteria

  • Subject having expressed its opposition to the reuse of its data for scientific research purposes.

Trial contacts and locations

1

Loading...

Central trial contact

Victor GABRIELE, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems